APOPHARMA USA Trademark Information

Apotex Technologies Inc.

Pharmaceutical preparations, namely, prescription drugs for the treatment of multiple myeloma by slowing the growth of cancer cells, prescription drugs for the treatment of multiple myeloma by stopping the growth of cancer cells, prescription drugs for palliative treatment of patients with multiple myeloma, and prescription drugs for use as an iron chelator for the treatment of patients with transfusion iron overload due to thalassemia syndrom...

Perfect for these industries

Words that describe this mark

pharmaceutical   preparations       prescription   drugs   treatment   multiple   myeloma   slowing   growth   cancer   cells     prescription   drugs   treatment   multiple   myeloma   stopping   growth   cancer   cells     prescription   drugs  

This is a brand page for the APOPHARMA USA trademark by Apotex Technologies Inc.  in Toronto, Ontario, , M9L1T9.

Write a review about a product or service associated with this APOPHARMA USA trademark. Or, contact the owner Apotex Technologies Inc. of the APOPHARMA USA trademark by filing a request to communicate with the Legal Correspondent for licensing, use, and/or questions related to the APOPHARMA USA trademark.

On Wednesday, March 30, 2016, a U.S. federal trademark registration was filed for APOPHARMA USA by Apotex Technologies Inc., Toronto, Ontario M9L1T9. The USPTO has given the APOPHARMA USA trademark serial number of 86958426. The current federal status of this trademark filing is PUBLISHED FOR OPPOSITION. The correspondent listed for APOPHARMA USA is ROBERT A. ROWAN of NIXON & VANDERHYE P.C., 901 N. GLEBE ROAD, 11TH FLOOR, ARLINGTON, VA 22203 . The APOPHARMA USA trademark is filed in the category of Pharmaceutical Products . The description provided to the USPTO for APOPHARMA USA is Pharmaceutical preparations, namely, prescription drugs for the treatment of multiple myeloma by slowing the growth of cancer cells, prescription drugs for the treatment of multiple myeloma by stopping the growth of cancer cells, prescription drugs for palliative treatment of patients with multiple myeloma, and prescription drugs for use as an iron chelator for the treatment of patients with transfusion iron overload due to thalassemia syndromes, prescription drugs for the treatment of iron-associated neurodegenerative conditions, namely, Parkinson's disease and neurodegeneration with brain iron accumulation, in particular, pantothenate kinase-associated neurodegeneration.

Word mark: APOPHARMA USA
Status/Status Date:
PUBLISHED FOR OPPOSITION
4/11/2017
Serial Number: 86958426
Filing Date: 3/30/2016
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Pharmaceutical preparations, namely, prescription drugs for the treatment of multiple myeloma by slowing the growth of cancer cells, prescription drugs for the treatment of multiple myeloma by stopping the growth of cancer cells, prescription drugs for palliative treatment of patients with multiple myeloma, and prescription drugs for use as an iron chelator for the treatment of patients with transfusion iron overload due to thalassemia syndromes, prescription drugs for the treatment of iron-associated neurodegenerative conditions, namely, Parkinson's disease and neurodegeneration with brain iron accumulation, in particular, pantothenate kinase-associated neurodegeneration
Mark Description: The mark consists of the word "APOPHARMA" with "USA" underneath and a swoosh design at the end.
Type Of Mark: TradeMark
Published For Opposition Date: 4/11/2017
Last Applicant/Owner: Apotex Technologies Inc.
Toronto, Ontario M9L1T9
Mark Drawing Code: Drawing/Design + Words
Design Search:
Curved line(s), band(s) or bar(s) (Geometric figures and solids - Lines, bands, bars, chevrons and angles) see more design...
Register Type: Principal
Disclaimer: ("USA")
Correspondent:
NIXON & VANDERHYE P.C.
901 N. GLEBE ROAD, 11TH FLOOR
ARLINGTON, VA 22203

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Trademarkia is the largest search engine for U.S. trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the LegalForce/Trademarkia network! You can register your trademark in 170+ countries in the world through LegalForce Network.

LegalForce Network can help you incorporate a business around your APOPHARMA USA trademark in less than 5 minutes. Trademarkia makes the process easy and convenient, so start now!

Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.

Trademark Document Retrieval >>

100% Satisfaction Guarantee protect your valuable brand now.

  • 1. Legalforce RAPC - #1 U.S. Trademark Filing from 2010 to now.
  • 2. Describe how your business or product is being used. Register your mark in 176+ countries. Just $199 + govt fees! Start here >>
  • 1. Top Global IP Attorneys - Credibility and Experience!
  • 2. All processes will be performed in a timely manner. You will be informed periodically about the process.
Keep Track of this Brand.

Trademark Watch Services

Keep track of how your trademark is being used. Available in the United States and in more than 176 countries. Round-the-clock monitoring. Monthly report on potential infringement.

Trademark Watch Services read more...
Current Trademark Status:
4/11/2017
PUBLISHED FOR OPPOSITION
Free Trademark Search:
Correspondent Search:

ROBERT A. ROWAN is a correspondent of APOPHARMA USA trademark.

Current Overall Rating:
RatingRatingRatingRatingRating (0 review)
What You Can Do:
Trademarkia lets you see how your personal name, product name, trademark name or username is being used on any of 530+ new and popular social networks. Be the first to reserve your name and get help stopping others from using it - all in one place!